FinQuota.com
Home
News
Screener
Backtests
Tools
Compare Stocks
Dividend Calculator
Options Calculator
NYSE Holidays
NASDAQ Holidays
Earnings Calendar
Filter
Dividend Stocks
US Dividend Stocks
Monthly Dividend Stocks
Annual Dividend Stocks
Quarterly Dividend Stocks
Semi-Annual Dividend Stocks
Best Penny Stocks
Undervalued Stocks
New Stocks
Uptrend Stocks
Uptrend Penny Stocks
Blue Chip
Blue Chip Stocks With High Dividends
Blue Chip Under $10
Blue Chip Under $20
Blue Chip Under $50
Undervalued Blue Chip Stocks
By Cap
Best Small Cap
Best Micro Cap
Best Mid Cap
Best Large Cap
By Sector
Oil Stocks
Energy Stocks
Technology Stocks
AI Stocks
Pharma Stocks
Financial Stocks
By Price
Under $200
Under $100
Under $50
Under $20
Under $10
Under $5
Under $1
By 52 Week Range
Best 52 Week Low
Best 52 Week Nasdaq Low
Best 52 Week NYSE Low
Best 52 Week Low Penny
Best 52 Week Low Blue Chip
Best 52 Week High
Best 52 Week Nasdaq High
Best 52 Week NYSE High
Best 52 Week High Penny
By Exchange
Best Nasdaq Stocks
Best NYSE Stocks
By Insider Activity
Insider Buying
Insider Selling
By Indicator
MACD Crossed Above Signal Line
MACD Crossed Above Zero
RSI Above 90
RSI Above 80
RSI Above 70
RSI Above 50
RSI Below 50
RSI Below 30
RSI Below 20
RSI Below 10
By P/E Ratio
Tech Stocks with Low PE
PE Ratio Less Than 1
PE Ratio Less Than 10
PE Ratio Less Than 15
US stocks With Low PE
Low PE & High Dividends
Low PE & High EPS
Large Cap & Lowest PE
Learning
Books
Trading Platforms
Forum
Auto (Default)
Light mode
Dark
Sign In
Sign Up
FinQuota.com
Home
Account
Sign In
Sign Up
News
Screener
Backtests
Tools
Compare Stocks
Dividend Calculator
Options Calculator
NYSE Holidays
NASDAQ Holidays
Earnings Calendar
Filter
Dividend Stocks
US Dividend Stocks
Monthly Dividend Stocks
Annual Dividend Stocks
Quarterly Dividend Stocks
Semi-Annual Dividend Stocks
Best Penny Stocks
Undervalued Stocks
New Stocks
Uptrend Stocks
Uptrend Penny Stocks
Blue Chip
Blue Chip Stocks With High Dividends
Blue Chip Under $10
Blue Chip Under $20
Blue Chip Under $50
Undervalued Blue Chip Stocks
By Cap
Best Small Cap
Best Micro Cap
Best Mid Cap
Best Large Cap
By Sector
Oil Stocks
Energy Stocks
Technology Stocks
AI Stocks
Pharma Stocks
Financial Stocks
By Price
Under $200
Under $100
Under $50
Under $20
Under $10
Under $5
Under $1
By 52 Week Range
Best 52 Week Low
Best 52 Week Nasdaq Low
Best 52 Week NYSE Low
Best 52 Week Low Penny
Best 52 Week Low Blue Chip
UBest 52 Week High
Best 52 Week Nasdaq High
Best 52 Week NYSE High
Best 52 Week High Penny
By Exchange
Nasdaq Stocks
NYSE Stocks
By Insider Activity
Insider Buying
Insider Selling
By Indicator
MACD Crossed Above Signal Line
MACD Crossed Above Zero
RSI Above 90
RSI Above 80
RSI Above 70
RSI Above 50
RSI Below 50
RSI Below 30
RSI Below 20
RSI Below 10
By P/E Ratio
Tech Stocks with Low PE
PE Ratio Less Than 1
PE Ratio Less Than 10
PE Ratio Less Than 15
US stocks With Low PE
Low PE & High Dividends
Low PE & High EPS
Large Cap & Lowest PE
Learning
Books
Trading Platforms
Forum
Search Ticker
Home
TRAW
TRAW News
Latest TRAWS PHARMA INC (TRAW) News on July 27, 2024
TRAW
Newsfile
2 months ago
Edge Total Intelligence Inc. Updates Status of MCTO
TRAW
GlobeNewswire
2 months ago
LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
TRAW
GlobeNewswire
2 months ago
Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
TRAW
GlobeNewswire
2 months ago
The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
TRAW
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
TRAW
GlobeNewswire
2 months ago
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
TRAW
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
TRAW
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
TRAW
GlobeNewswire
2 months ago
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
TRAW
GlobeNewswire
2 months ago
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
TRAW
GlobeNewswire
3 months ago
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
TRAW
Simply Wall St.
4 months ago
Traws Pharma Full Year 2023 Earnings: Beats Expectations
Share on Social Networks: